Neoadjuvant chemotherapy induces phenotypic mast cell changes in high grade serous ovarian cancer
Abstract Background High grade serous ovarian cancer (HGSOC) is the most lethal gynecologic malignancy in which patients have still yet to respond meaningfully to clinically available immunotherapies. Hence, novel immune targets are urgently needed. Our past work has identified that mast cells are s...
Сохранить в:
Главные авторы: | , , , , , , , , |
---|---|
Формат: | |
Опубликовано: |
BMC,
2024-09-01T00:00:00Z.
|
Предметы: | |
Online-ссылка: | Connect to this object online. |
Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|
Internet
Connect to this object online.3rd Floor Main Library
Шифр: |
A1234.567 |
---|---|
Копировать 1 | Доступно |